Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease

Journal of Clinical Investigation

Volumn 101, Issue 9, 1998, Pages 1827-1834

  Mizuno, Shinya ^a   Kurosawa, Tsutomu ^a   Matsumoto, Kunio ^a   Mizuno Horikawa, Yoko ^a   Okamoto, Munehiro ^a   Nakamura, Toshikazu ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Chronic renal failure; Glomerulosclerosis; HGF therapy; Kidney; Tubular proliferation

Indexed keywords

SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL MODEL; ARTICLE; CHRONIC KIDNEY DISEASE; DIET SUPPLEMENTATION; DRUG USE; GLOMERULOSCLEROSIS; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY TUBULE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0032080835     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI1709     Document Type: Article

References (48)

1. Lazarus, J.M., B.M. Denker, and W.F. Owen. 1996. Hemodialysis. In The Kidney 5th Ed. B.M. Brenner, editor. W.B. Saunders, Philadelphia. 2424-2506.
2. Brenner, B.M., T.W. Meyer, and T.H. Hostetter. 1982. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N. Engl. J. Med. 307:652-659.
3. Ong, A.C., and L.G. Fine. 1994. Loss of glomerular function and tubulointerstitial fibrosis: cause or effect? Kidney Int. 45:345-351.
4. Risdon, R.A., J.C. Sloper, and H.E. Wardener. 1968. Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis. Lancet. 2:363-366.
5. Bohle, A., F. Strutz, and G.A. Muller. 1994. On the pathogenesis of chronic renal failure in primary glomerulopathies: a view from the interstitium. Exp. Nephrol 2:205-210.
6. Eddy, A.A. 1996. Molecular insights into renal interstitial fibrosis. J. Am. Soc. Nephrol. 7:2495-2508.
7. Kliem, V., R.J. Johnson, C.E. Alpers, A. Yoshimura, W.G. Couser, K.M. Koch, and J. Floege. 1996. Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats. Kidney Int. 49:666-678.
8. Lloyd, C.M., A.W. Minto, M.E. Dorf, A. Proudfoot, T.N.C. Wells, D.J. Salant, and J.C. Gutierrez-Ramos. 1997. RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis. J Exp. Med. 185:1371-1380.
9. Hostetter, T.H. 1995. Progression of renal disease and renal hypertrophy. Annu. Rev. Physiol. 57:263-278.
10. Nakamura, T., T. Nishizawa, M. Hagiya, T. Seki, M. Shimonishi, A. Sugimura, K. Tashiro, and S. Shimizu. 1989. Molecular cloning and expression of human hepatocyte growth factor. Nature. 342:440-443.
11. Miyazawa, K., H. Tsubouchi, D. Naka, K. Takahashi, M. Okigaki, N. Arakaki, H. Nakayama, S. Hirono, O. Sakiyama, K. Takahashi, et al. 1989. Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem. Biophys. Res. Commun. 163:967-973.
12. Igawa, T., S. Kanda, H. Kanetake, Y. Saitoh, A. Ichihara, Y. Tomita, and T. Nakamura. 1991. Hepatocyte growth factor is a potent mitogen for cultured rabbit renal tubular epithelial cells. Biochem. Biophys. Res. Commun. 174:831-838.
13. Montesano, R., K. Matsumoto, T. Nakamura, and L. Orci. 1991. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell. 67:901-908.
14. Nagaike, M., S. Hirao, H. Tajima, S. Noji, S. Taniguchi, K. Matsumoto, and T. Nakamura. 1991. Renotropic functions of hepatocyte growth factor in renal regeneration after unilateral nephrectomy. J. Biol. Chem. 266:22781-22784.
15. Joannidis, M., K. Spokes, T. Nakamura, D. Faletto, and L.G. Cantley. 1994. Regional expression of hepatocyte growth factor/c-met in experimental renal hypertrophy and hyperplasia. Am. J. Physiol. 267:F231-F236.
16. Kawaida, K., K. Matsumoto, H. Shimazu, and T. Nakamura. 1994. Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc. Natl. Acad. Sci. USA. 91:4357-4361.
17. Miller, S.B., D.R. Martin, J. Kissane, and M.R. Hammerman. 1994. Hepatocyte growth factor accelerates recovery from acute ischemic renal injury in rats. Am. J. Physiol. 266:F129-F134.
18. Kurosawa, T., M. Okamoto, K. Yamada, and B.F. Yue. 1993. Nephrosis (nep): a new mouse mutation which causes albuminuria and other symptoms of nephrosis. Mouse Genome. 91:876-879.
19. Ogura, A., T. Asano, O. Suzuki, Y. Yamamoto, Y. Noguchi, H. Kawaguchi and Y. Yamaguchi. 1994. Hereditary nephrotic syndrome with progression to renal failure in a mouse model (ICON strain): clinical study. Nephron. 68:239-244.
20. Mizuno, S., B.F. Yue, M. Okamoto, Y. Horikawa, and T. Kurosawa. 1997. Diffuse glomerulosclerosis without tubular injury does not directly manifest renal dysfunction in nephrotic mice (ICGN strain). Exp. Nephrol. 5:498-507.
21. Shima, N., E. Tsuda, M. Goto, K. Yano, H. Hayasaka, M. Ueda, and K. Higashio. 1994. Hepatocyte growth factor and its variant with a deletion of five amino acids are distinguishable in their biological activity and tertiary structure. Biochem. Biophys. Res. Commun. 200:808-815.
22. Raij, L., S. Azar, and W. Keane. 1984. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int. 26:137-143.
23. Floege, J., R.J. Johnson, K. Gordon, H. Iida, P. Pritzl, A. Yoshimura, C. Campbell, C.E. Alpers, and W.G. Couser. 1991. Increased synthesis of extracellular matrix in mesangial proliferate nephritis. Kidney Int. 40:477-488.
24. Yo, Y., R. Morishita, J. Higaki, I. Kida, A. Moriguchi, M. Aoki, S. Kato, K. Matsumoto, T. Nakamura, and T. Ogihara. 1998. Function of hepatocyte growth factor as a local modulator in the kidney: potential role in pathogenesis of renal disease. Kidney Int. 53:50-58.
25. Laurens, W., C. Battaglia, C. Foglieni, R. Vos, B. Malanchini, B.V. Damme, Y. Vanrenterghem, G. Remuzzi, and A. Remuzzi. 1995. Direct podocyte damage in the single nephron leads to albuminuria in vivo. Kidney Int. 47:1078-1086.
26. Takehara, T., K. Matsumoto, and T. Nakamura. 1992. Cell density-dependent regulation of albumin synthesis and DNA synthesis in rat hepatocytes by hepatocyte growth factor. J. Biachem. 112:330-334.
27. Matsuda, Y., K. Matsumoto, T. Ichida, and T. Nakamura. 1995. Hepatocyte growth factor suppresses the onset of liver cirrhosis and abrogates lethal hepatic dysfunction in rats. J. Biochem. 118:643-649.
28. Tang, W.W., T.R. Ulich, D.L. Lacey, D.C. Hill, M. Qi, S.A. Kaufman, G.Y. Van, J.E. Tarpley, and J.S. Yee. 1996. Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis. Am. J. Pathol. 148:1169-1180.
29. Border, W.A., and N.A. Noble. 1994. Transforming growth factor beta in tissue fibrosis. N. Engl. J. Med. 331:1286-1292.
30. Mizuno, S., Y. Mizuno-Horikawa, M. Okamoto, and T. Kurosawa. 1998. ACE inhibitor suppresses tubular expression of PDGF and attenuates progression of tubulo-interstitial fibrosis in a nephrotic mouse model. Nephron. In press.
31. Knecht, A., L.G. Fine, K.S. Kleinman, H.P. Rodemann, G.A. Muller, D.D. Woo, and J.T. Norman. 1991. Fibroblasts of rabbit kidney in culture. II. Paracrine stimulation of papillary fibroblasts by PDGF. Am. J. Physiol. 261: F292-F299.
32. Zarnegar, R., and G.K. Michalopoulos. 1995. The many faces of hepatocyte growth factor from hepatopoiesis to hematopoiesis. J. Cell Biol. 129:1177-1180.
33. Ishiki, Y., H. Ohnishi, Y. Muto, K. Matsumoto, and T. Nakamura. 1992. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology. 16:1227-1235.
34. Yasuda, H., E. Imai, A. Shiota, N. Fujise, T. Morinaga, and K. Higashio. 1996. Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats. Hepatology. 24:636-642.
35. Matsuda, Y., K. Matsumoto, A. Yamada, T. Ichida, H. Asakura, Y. Komoriya, E. Nishiyama, and T. Nakamura. 1997. Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis. Hepatology. 26:81-89.
36. Yaekashi, M., S. Nakamura, K. Ohnuma, T. Sasaki, T. Abe, K. Satoh, K. Matsumoto, T. Nakamura, T. Takahashi, and T. Nukiwa. 1997. Simultaneous or delayed administration of hepatocyte growth factor (HGF) equally repress the fibrotic changes in murine lung injury by bleomycin: a morphological study. Am. J. Respir. Clin. Care Med. 156:1937-1944.
37. Ishibashi, K., S. Sasaki, H. Sakamoto, Y. Nakamura, T. Hata, T. Nakamura, and F. Marumo. 1992. Hepatocyte growth factor is a paracrine factor for renal epithelial cells: stimulation of DNA synthesis and Na,K-ATPase activity. Biochem. Biophys. Res. Commun. 182:960-965.
38. Barrow, E.J.G., O.F.T. Santos, K. Matsumoto, T. Nakamura, and S.K. Nigam. 1995. Differential lubulogenic and branching morphogenetic activities of growth factors: implications for epithelial tissue development. Proc. Natl. Acad. Sci. USA. 92:4412-4416.
39. Sonnenberg, E., D. Meyer, K.M. Weidner, and C. Birchmeier. 1993. Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J. Cell Biol. 123:223-235.
40. Woolf, A.S., M. Kolatsi-Joannou, P. Hardman, E. Andermarcher, C. Moorby, L.G. Fine, P.S. Jat, M.D. Noble, and E. Gherardi. 1995. Role of hepatocyte growth factor/scatter factor and the Met receptor in the early development of the metanephron. J. Cell Biol. 128:171-184.
41. Nahas, A.M.E., K.E. Muchaneta, G. Zhang, A. Adam, and D. Goumenos. 1996. Phenotypic modulation of renal cells during experimental and clinical renal scarring. Kidney Int. 49(Suppl.):S23-S27.
42. Alpers, C.E., K.L. Hudkins, J. Floege, and R.J. Johnson. 1994. Human renal cortical cells with some features of smooth muscle cells participate in tubulointerstitial and crescentic glomerular injury. J. Am. Soc. Nephrol. 5:201-210.
43. Morishita, R., S. Nakamura, Y. Nakamura, M. Aoki, A. Moriguchi, I. Kida, Y. Yo, K. Matsumoto, T. Nakamura, J. Higaki, and T. Ogihara. 1997. Potential role of an endothelium-specific growth factor, hepatocyte growth factor, on endothelial damage in diabetes. Diabetes. 46:138-142.
44. Isaka, Y., Y. Fujiwara, N. Ueda, Y. Kaneda, T. Kamada, and E. Imai. 1993. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney. J. Clin. Invest. 92:2597-2601.
45. Isaka, Y., D.K. Brees, K. Ikegaya, Y. Kaneda, E. Imai, N.A. Noble, and W.A. Border. 1996. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nature Med. 2:418-423.
46. Johnson, R.J., E.W. Raines, J. Floege, A. Yoshimura, P. Pritzl, C. Alpers, and R. Ross. 1992. Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp. Med. 175:1413-1416.
47. Takayama, H., W.J. LaRochelle, S.G. Sabnis, T. Otsuka, and G. Merlino. 1997. Renal tubular hyperplasia, polycystic disease, and glomerulosclerosis in transgenic mice overexpressing hepatocyte growth factor/scatter factor. Lab. Invest. 77:131-138.
48. Shiota, G., T.C. Wang, T. Nakamura, and E.V. Schmidt. 1994. Hepatocyte growth factor in transgenic mice: effects on hepatocyte growth factor, liver generation and gene expression. Hepatology. 19:962-972.